Table 1.
Three-way ANOVA results of mitochondria degradation curve in Figure 8A
| ANOVA table | SS | DF | MS | F (DFn, DFd) | P value |
|---|---|---|---|---|---|
| Time | 28,229 | 2 | 14,114 | F (2, 114) = 628.7 | P < 0.0001 |
| FCCP* | 1040 | 1 | 1040 | F (1, 114) = 46.30 | P < 0.0001 |
| Mutation | 425.3 | 1 | 425.3 | F (1, 114) = 18.94 | P < 0.0001 |
| Time x FCCP* | 1439 | 2 | 719.6 | F (2, 114) = 32.05 | P < 0.0001 |
| Time x Mutation | 447.2 | 2 | 223.6 | F (2, 114) = 9.960 | P = 0.0001 |
| FCCP* x Mutation | 112.4 | 1 | 112.4 | F (1, 114) = 5.006 | P = 0.0272 |
| Time x FCCP* x Mutation | 131.3 | 2 | 65.65 | F (2, 114) = 2.924 | P = 0.0578 |
| Residual | 2559 | 114 | 22.45 |
Statistical significance between groups was analyzed by three-way ANOVA for mitochondria degradation using GraphPad Prism™ ver. 8. *Data from 10 µM FCCP treatment groups were used for analysis.